公开(公告)号：US20210355205A1

公开(公告)日：2021-11-18

申请号：US17385532

申请日：2021-07-26

Applicant: Cephalon, Inc.

Inventor： Mark Terence Liddament ,  Anthony Doyle ,  Adam Clarke ,  David Jose Simon Laine ,  Bridget Ann Cooksey

IPC: C07K16/24 ,  A61P37/08

Abstract: Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an equilibrium affinity constant (KD) of at least about 40 pM as determined by surface plasmon resonance.

公开(公告)号：US20180186873A1

公开(公告)日：2018-07-05

申请号：US15848090

申请日：2017-12-20

Applicant: Cephalon, Inc.

Inventor： Mark Terence Liddament ,  Anthony Doyle ,  Adam Clarke ,  David Jose Simon Laine ,  Bridget Ann Cooksey

IPC: C07K16/24

Abstract: Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an equilibrium affinity constant (KD) of at least about 40 pM as determined by surface plasmon resonance.

公开(公告)号：US11111292B2

公开(公告)日：2021-09-07

申请号：US15848090

申请日：2017-12-20

Applicant: Cephalon, Inc.

Inventor： Mark Terence Liddament ,  Anthony Doyle ,  Adam Clarke ,  David Jose Simon Laine ,  Bridget Ann Cooksey

IPC: C07K16/24 ,  A61P37/08 ,  A61K39/00 ,  C07K14/54

Abstract: Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an equilibrium affinity constant (KD) of at least about 40 pM as determined by surface plasmon resonance.